Legend Biotech (LEGN) Change in Account Payables (2019 - 2025)
Legend Biotech (LEGN) posted Change in Account Payables of $24.3 million for Q3 2025, up 46.85% on a QoQ basis from $16.5 million in Q2 2025, and up 289.32% year-over-year from $6.2 million in Q3 2024.
Legend Biotech (LEGN) has 7 years of Change in Account Payables data on file, last reported at $24.3 million in Q3 2025.
- In Q3 2025, Change in Account Payables rose 289.32% year-over-year to $24.3 million; the TTM figure through Sep 2025 stood at $66.3 million (up 350.74% YoY), while the FY2024 annual figure was $14.1 million, up 128.01% from the prior year.
- Change in Account Payables advanced to $24.3 million in Q3 2025, from $16.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $41.9 million in Q4 2022 and bottomed at -$34.5 million in Q4 2023.
- A 5-year average of $6.4 million and a median of $6.0 million in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 157597.82% — and 2023, when it sank 430.02%.
- Year by year, Change in Account Payables stood at -$4.6 million in 2021, then jumped by 1021.8% to $41.9 million in 2022, then slumped by 182.21% to -$34.5 million in 2023, then surged by 117.51% to $6.0 million in 2024, then soared by 302.04% to $24.3 million in 2025.
- The last three Change in Account Payables figures came in at $24.3 million (Q3 2025), $16.5 million (Q2 2025), and $19.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 16.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 24.27 Mn |
| Sep 30, 2025 | 24.27 Mn |
| Jun 30, 2025 | 16.53 Mn |
| Jun 30, 2025 | 16.53 Mn |
| Mar 31, 2025 | 19.51 Mn |
| Mar 31, 2025 | 19.51 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Sep 30, 2024 | -12.82 Mn |
| Sep 30, 2024 | -12.82 Mn |
| Jun 30, 2024 | -1.95 Mn |
| Jun 30, 2024 | -1.95 Mn |
| Mar 31, 2024 | 22.80 Mn |
| Mar 31, 2024 | 22.80 Mn |
| Dec 31, 2023 | -34.48 Mn |
| Dec 31, 2023 | -34.48 Mn |
| Sep 30, 2023 | -4.37 Mn |
| Sep 30, 2023 | -4.37 Mn |
| Jun 30, 2023 | -8.27 Mn |
| Jun 30, 2023 | -8.27 Mn |
| Mar 31, 2023 | -3.08 Mn |
| Mar 31, 2023 | -3.08 Mn |
| Dec 31, 2022 | 41.94 Mn |
| Dec 31, 2022 | 41.94 Mn |
| Sep 30, 2022 | 25.33 Mn |
| Sep 30, 2022 | 25.33 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 2.67 Mn |
| Mar 31, 2022 | 2.67 Mn |
| Dec 31, 2021 | -4.55 Mn |
| Dec 31, 2021 | -4.55 Mn |
| Sep 30, 2021 | 11.59 Mn |
| Sep 30, 2021 | 11.59 Mn |
| Jun 30, 2021 | 11.00 Mn |
| Jun 30, 2021 | 11.00 Mn |
| Mar 31, 2021 | 4.41 Mn |
| Mar 31, 2021 | 4.41 Mn |
| Dec 31, 2020 | -4.35 Mn |
| Dec 31, 2020 | -4.35 Mn |
| Sep 30, 2020 | 7,399.00 |
| Sep 30, 2020 | 7,399.00 |
| Jun 30, 2020 | 6,976.00 |
| Jun 30, 2020 | 6,976.00 |
| Dec 31, 2019 | 9,586.00 |
| Dec 31, 2019 | 9,586.00 |